IMC Chicago’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Buy
228,600
+129,500
+131% +$5.85M ﹤0.01% 1436
2026
Q1
$3.77M Sell
99,100
-85,600
-46% -$3.61M ﹤0.01% 2032
2025
Q4
$9.55M Sell
184,700
-28,500
-13% -$1.74M ﹤0.01% 1263
2025
Q3
$15.9M Sell
213,200
-16,600
-7% -$1.22M 0.01% 891
2025
Q2
$17.6M Buy
229,800
+23,200
+11% +$1.67M 0.01% 754
2025
Q1
$14.4M Sell
206,600
-59,600
-22% -$4.12M 0.01% 722
2024
Q4
$16.3M Buy
266,200
+38,400
+17% +$2.51M 0.01% 695
2024
Q3
$13.5M Buy
227,800
+107,700
+90% +$5.92M 0.01% 709
2024
Q2
$6.83M Buy
120,100
+44,500
+59% +$2.73M ﹤0.01% 929
2024
Q1
$4.67M Buy
+75,600
New +$4.36M ﹤0.01% 997

Other funds holding NTNX

IMC Chicago's NTNX Position: Q2 2026 in Review

IMC Chicago reduced its Nutanix (NTNX) stake by 28% in Q2 2026, selling an estimated $375K and leaving 20,996 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #3778.

IMC Chicago first reported a position in NTNX in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.62M in Q4 2025. 564 funds tracked by Wall St. Rank hold NTNX as of Q2 2026.

  • IMC Chicago held 20,996 shares of Nutanix worth $1.07M as of Q2 2026.
  • IMC Chicago sold 8,300 Nutanix shares in Q2 2026, an estimated $375K.
  • Nutanix made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3778 holding.
  • IMC Chicago first reported a position in Nutanix in Q3 2025 and has held it in 4 quarters since.
  • IMC Chicago's Nutanix position peaked at $3.62M in Q4 2025.
  • 564 funds tracked by Wall St. Rank held Nutanix as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.